CDEK
← Mechanisms of action

Cytomegalovirus

ORGANISMCytomegalovirus

Drugs acting on this target (56)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
trl345AntagonistexperimentalmAbcytomegalovirus
asp0113Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
avx601Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
bd03Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
cmv gb vaccineImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
cmv pp65 peptideImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
cmv vaccineImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
cmv-dcsImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
cmv-mvaImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
CMVsuImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
cymvectinImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
gsk1492903aImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
gsk2592984aImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
hb-101Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
human cmv pp65-lamp mrna-pulsed autologous dcsImmunity, activeexperimentalCell therapyCytomegalovirus immunity, active
mrna-1443Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
mrna-1647Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
pep-cmvImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
pp65 rna loaded lipid particles, pp65 rna-lpsImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
SPYVLP01Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
tetanus-cmv fusion peptide vaccineImmunity, activeexperimentalVaccineCytomegalovirus immunity, active
v160Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
vbi-1501Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
vcl-cb01Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
vcp260Immunity, activeexperimentalVaccineCytomegalovirus immunity, active
allogeneic cytomegalovirus-specific cytotoxic t lymphocytesImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
autologous cmv-specific ctlImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cmv-specific t-cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cmv-vstImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cmv/adv /ebv/bkv specific t cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cmv/adv specific t cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cmv/ebv specific t-cellImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cmv/hiv-car t cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cytomegalovirus ie-1-specific cytotoxic t lymphocytesImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cytomegalovirus immune globulin intravenous (human) (cytogam)Immunity, passiveapprovedBiologicalCytomegalovirus immunity, passive
cytomegalovirus pp65-specific cytotoxic t lymphocytesImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cytomegalovirus-specific cytotoxic t cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
cytomegalovirus-specific t-cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
hcmv-specific hyperimmune globulinImmunity, passiveexperimentalBiologicalCytomegalovirus immunity, passive
immunecellvirImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
mcmv3068aImmunity, passiveexperimentalmAbCytomegalovirus immunity, passive
mcmv5322aImmunity, passiveexperimentalmAbCytomegalovirus immunity, passive
multivirus (cmv, ebv, adv)-specific t cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
multivirus specific t cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
pentavalent-specific t cells (penta-sts)Immunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
PosoleucelImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
regavirumabImmunity, passiveexperimentalmAbCytomegalovirus immunity, passive
sevirumabImmunity, passiveexperimentalmAbCytomegalovirus immunity, passive
tcn-202Immunity, passiveexperimentalmAbCytomegalovirus immunity, passive
tri-virus specific cytotoxic t-cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
trivirus specific ctls for ebv, cmv and adenovirus infectionImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
virus-specific T cellsImmunity, passiveexperimentalCell therapyCytomegalovirus immunity, passive
csj148InhibitorexperimentalmAbCytomegalovirus inhibitor
npc-21InhibitorexperimentalmAbCytomegalovirus inhibitor
rg7667InhibitorexperimentalmAbCytomegalovirus inhibitor
sevirumabInhibitorexperimentalmAbCytomegalovirus inhibitor